SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

NBIS is trending amid news of increased AI infrastructure investments and partnerships involving Nvidia, Microsoft, and OpenAI. The community is bullish, anticipating strong earnings and speculating on potential deals with major players, driving discussions about price targets and market capitalization. Some users point to potential deals with AMZN as a catalyst.

Mannatech, Inc. engages in the development of nutritional supplements, topical and skin care products and weight-management products that target optimal health and wellness. Its product category includes integrative health, targeted health, wealth and fitness, skin care, essentials, and home. The company was founded by Marlin Ray Robbins and Samuel L. Caster in November 1993 and is headquartered in Flower Mound, TX.

Mannatech Inc

MTEX is trending as traders focus on its low float and potential for a significant price surge. Community discussions highlight the stock's recent momentum and anticipation for a breakout, with some comparing it to other low-float runners like $HKD. The stock's technical setup and recent volume suggest a potential squeeze, attracting both day traders and those looking for multi-day gains.

Zcash is a decentralized and open-source cryptocurrency that offers privacy and selective transparency of transactions. Zcash payments are published on a public blockchain, but the sender, recipient, and amount of a transaction remain private.  Zcash is based on peer-reviewed cryptographic research, and built by a security-specialized engineering team on an open source platform based on Bitcoin Core's battle-tested codebase. Our improvement over Bitcoin is the addition of privacy. Zcash uses advanced cryptographic techniques, namely zero-knowledge proofs, to guarantee the validity of transactions without revealing additional information about them.  How Zcash works  Zcash encrypts the contents of shielded transactions. Since the payment information is encrypted, the protocol uses a novel cryptographic method to verify their validity.  Zcash uses a zero-knowledge proof construction called a zk-SNARK, developed by our team of experienced cryptographers based on recent breakthroughs in cryptography. These constructions allow the network to maintain a secure ledger of balances without disclosing the parties or amounts involved. Instead of publicly demonstrating spend-authority and transaction values, the transaction metadata is encrypted and zk-SNARKs are used to prove that nobody is cheating or stealing.  Zcash also enables users to send public payments which work similarly to Bitcoin. With the support for both shielded and transparent addresses, users can choose to send Zcash privately or publicly. Zcash payments sent from a shielded address to a transparent address reveal the received balance, while payments from a transparent address to a shielded address protect the receiving value.   Check out CoinBureau for guide on What is ZCash.

Zcash

Zcash is trending as it breaks multi-year highs, with the community actively discussing its potential as 'the better Bitcoin' due to its privacy features and limited supply. Some believe influencers are promoting ZEC, contributing to strong buying pressure, while others anticipate a continued run towards significantly higher prices and compare it to Bitcoin's early days. The upcoming halving event is also fueling excitement.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending due to a potential bidding war with Novo Nordisk for Metsera, a company developing obesity drugs, after Novo Nordisk made a higher bid. The community is discussing the implications of this deal, including potential antitrust issues, and whether Pfizer will counter or pursue alternative acquisitions like Viking Therapeutics. Some investors express frustration with Pfizer's stock performance despite positive news, focusing on its dividend yield and potential for a turnaround.

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy is trending amid increasing interest in fuel cell technology and growing demand for reliable power solutions, particularly as a cleaner alternative for data centers. Community discussions highlight the potential for partnerships and significant deals, drawing comparisons to sector peer Bloom Energy's recent surge. Additionally, some investors express optimism about FuelCell's technology and strategic positioning for the expanding AI energy market.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

SMCI is trending amid a flurry of news surrounding AI infrastructure and partnerships with NVIDIA, fueling optimism about the company's role in the AI sector. Community members are actively discussing the potential for significant revenue growth and margin expansion, especially with new U.S. federal opportunities. Some are concerned about management's execution and financial reporting, while others remain bullish, anticipating a breakout driven by increasing AI infrastructure spending.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is trending amid ongoing discussion around AI infrastructure buildout and potential partnerships, particularly related to the U.S. Department of Energy and supercomputing. Community members are weighing the significance of these deals against concerns about the company's debt and insider selling, while also awaiting potential news regarding a TikTok agreement. The stock's recent performance and potential for future growth in the competitive AI landscape are key points of conversation.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as digital video compact disc player, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

TSM is trending due to positive news surrounding NVDA partnerships and the AI sector, with mentions of AI infrastructure build-out and potential for growth. The community is watching TSM's key role in AI, but some are concerned about broader market manipulation and geopolitical risks between the U.S. and China. Put buying and concerns around high historical valuations are also being discussed.

Pitbull

Pitbull ($PIT) is trending due to recent listings on LF Wallet and partnerships with TokenPlay AI, expanding its reach and utility. The community is rallying around these developments, emphasizing the token's strong, decentralized foundation and potential for growth. Discussions highlight its unique contract design and long-term vision within the meme coin sector.

Based Chad

$CHAD is trending as community members express bullish sentiment, with some highlighting mentions from Coinbase executives and the anticipation of a Base airdrop. The focus remains on community engagement, accumulating, and 'bulking' positions, while some anticipate potential integration with an upcoming video game. Community members are drawing attention to the meme's broad recognition, cross-cultural appeal, and a growing number of use cases.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Bristol Myers Squibb Reports Third Quarter Financial Results for 2025

Bristol Myers Squibb (NYSE: BMY) today reported third quarter 2025 financial results. Visit the companys Investor Relations website at http://investor.bms.com to view the detailed third quarter 2025...

Key Events This Extremely Busy Week: Central Banks, Earnings Galore, And Trump-Xi Summit

Key Events This Extremely Busy Week: Central Banks, Earnings Galore, And Trump-Xi Summit As noted earlier, investors face a monumentally important and extremely busy week ahead that includes rates...

Bristol Myers Squibb Presents Two Late-Breaking Presentations Demonstrating Sotyktu (deucravacitinib) Efficacy in Psoriatic Arthritis and Systemic Lupus Erythematosus

Bristol Myers Squibb (NYSE:BMY) today announced Week 52 data from the pivotal Phase 3 POETYK PsA-1 trial further confirming the efficacy and safety of Sotyktu (deucravacitinib) in adults with active...

Bristol Myers Squibb Presents Encouraging Data from Phase 1 Breakfree-1 Study of CD19 NEX-T CAR T Cell Therapy in Three Chronic Autoimmune Diseases at ACR Convergence 2025

Bristol Myers Squibb (NYSE: BMY) today announced updated data and first disclosure of results in chronic, refractory autoimmune diseases from the Phase 1 Breakfree-1 study (NCT05869955) of its...

SystImmune, Inc. and Bristol Myers Squibb Announce First Global Phase I Results of Iza-bren, an EGFR x HER3 Bispecific Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors at ESMO 2025

SystImmune, Inc. and Bristol Myers Squibb Announce First Global Phase I Results of Iza-bren, an EGFR x HER3 Bispecific Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors at ESMO 2025...

Bristol Myers Squibb to Present Data at ESMO 2025 Showcasing Progress of Oncology Portfolio Across Diverse Tumor Types

Bristol Myers Squibb (NYSE: BMY) today announced the presentation of data across its oncology portfolio and pipeline at the European Society for Medical Oncology (ESMO) Congress 2025 to be held from...

SystImmune to Receive Milestone Payment from Bristol Myers Squibb Under Iza-Bren Collaboration

SystImmune to Receive Milestone Payment from Bristol Myers Squibb Under Iza-Bren Collaboration SystImmune to Receive Milestone Payment from Bristol Myers Squibb Under Iza-Bren Collaboration PR...

Bristol Myers Squibb Strengthens and Diversifies Cell Therapy Portfolio with Acquisition of Orbital Therapeutics

Bristol Myers Squibb (NYSE: BMY, BMS) and Orbital Therapeutics (Orbital) today announced a definitive agreement under which BMS will acquire Orbital, a privately held biotechnology company pioneering...

Bristol Myers Squibb and TV Host Gail Simmons Tackle Stigma in Schizophrenia with New Initiative Spotlighting the Power of Support and Connection

Bristol Myers Squibb (NYSE: BMY) today announced the launch of its COBENFY Connections initiative in partnership with culinary expert, TV host and author Gail Simmons.* Launching on World Mental...

Bristol Myers Squibbs Supplemental New Drug Application (sNDA) for Sotyktu (deucravacitinib) for the Treatment of Adults with Active Psoriatic Arthritis Accepted for Review Across Four Regions Globally

Bristol Myers Squibb (NYSE:BMY) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the supplemental New Drug Application (sNDA) for Sotyktu (deucravacitinib) for...

Will Palantir ($PLTR) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Palantir Technologies Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

CELG
Celgene Corporation

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest CELG News

CELGCelgene Corporation